Volver a resultados
Ficha bibliográfica · Consulta y acceso
Artículo

Immune dysfunction in cirrhosis: distinct cytokines phenotypes according to cirrhosis severity

Dirchwolf, Melisa et al · Elsevier · 2016

Material complementario disponible
Lectura rápida. Revisá los datos básicos del recurso y luego accedé al contenido desde el botón principal. En esta ficha solo se muestra la información necesaria para identificar la obra, citarla y abrirla.

Acceso al recurso

Entrá al contenido desde la opción principal o elegí otra fuente disponible.

CONICET Digital CONICET Digital OAI-PMH
Entrar por CONICET Digital
Acceso principal

Material complementario disponible

El enlace apunta a material asociado, anexos, tablas, datos o página complementaria. No se marca como libro/texto completo.
Abrir material

Resumen

Descripción general del contenido del recurso.

BACKGROUND/OBJECTIVES: Cirrhosis associated immune dysfunction has been proposed to switch from a pro-inflammatory phenotype in stable cirrhosis to an immunodeficient one in patients with decompensated cirrhosis and acute-on-chronic liver failure. The aim of the present study was to compare serum cytokine levels between healthy patients, stable cirrhosis, and decompensated cirrhotic patients with and without development of acute-on-chronic liver failure (ACLF); and to explore whether any of the measured cytokines is associated with cirrhosis severity and prognosis in ACLF patients. METHODS: Patients were enrolled from October 2013 to May 2014 in two hospitals located in Buenos Aires. Cirrhotic patients with an acute decompensating event were enrolled accordingly to the development of ACLF defined by the CANONIC study group. There were two control groups: healthy subjects (n=14) and stable cirrhotic patients (n=14). Demographic, clinical and biochemical data were obtained. Seventeen cytokines were measured using Bio-Plex Pro Human Cytokine 17-plex Assay. RESULTS: Of the 49 decompensated cirrhotic patients enrolled, 18 (36.7%) developed ACLF. Leukocyte count, MELD score at admission, Clif-SOFA at admission and day 7 were significantly higher in the ACLF group (p=0.046, p<0.001, p<0.001, p<0.001 respectively) as well as short-term mortality (p<0.001) compared to stable and decompensated cirrhotic patients. In comparison with healthy controls, stable cirrhotic and decompensated cirrhotic patients showed increased levels of pro-inflammatory and anti-inflammatory cytokines: IL-6, IL-7, IL-8, IL-10, IL 12, and TNF-α. Decompensated cirrhotic patients with the development of ACLF showed a significant decrease of IL-7, IL-10, IL-12, TNF-α, MCP-1 and IFN-γ, but a sustained response of IL-6 and IL-8. When evaluating cirrhosis severity, IL-6 and IL-8 correlated positively with MELD score, whereas only IL-6 correlated positively with Clif-SOFA score at day 7; IL-2 correlated negatively with Clif-SOFA at admission. In comparison with all scores, leukocyte count showed positive correlation and IFN-γ negative correlation with disease severity. When evaluating survival, only MELD and Clif-SOFA scores had a significant association with mortality. CONCLUSIONS: Pro-inflammatory cytokines and chemo-attractant elements are increased in cirrhosis in comparison with healthy subjects, and display higher values concomitantly with cirrhosis progression. However, in acute-on-chronic liver failure an opposite cytokine pattern that can be resumed as a combination of immune paresis and excessive inflammatory response was observed. Several pro-inflammatory cytokines (IL-2, IL-6, IL-8 and IFN-γ) showed correlation with disease severity; their utility as prognostic biomarkers needs to be further studied. Fil: Dirchwolf, Melisa. Gobierno de la Ciudad de Buenos Aires. Hospital de Infecciosas "Dr. Francisco Javier Muñiz"; Argentina Fil: Podhorzer, Ariel. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Inmunología, Genética y Metabolismo. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Inmunología, Genética y Metabolismo; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina

Cómo citar

Elegí el formato que necesitás y copiá la referencia al portapapeles.

APA 7

Dirchwolf, M. E. A. (2016). Immune dysfunction in cirrhosis: distinct cytokines phenotypes according to cirrhosis severity. http://hdl.handle.net/11336/18699

MLA

Dirchwolf, Melisa et al. "Immune dysfunction in cirrhosis: distinct cytokines phenotypes according to cirrhosis severity." 2016. http://hdl.handle.net/11336/18699.

Chicago

Dirchwolf, Melisa et al. 2016. "Immune dysfunction in cirrhosis: distinct cytokines phenotypes according to cirrhosis severity.". http://hdl.handle.net/11336/18699.

Harvard

Dirchwolf, M. E. A. 2016, Immune dysfunction in cirrhosis: distinct cytokines phenotypes according to cirrhosis severity, Elsevier, available at: http://hdl.handle.net/11336/18699 [Accessed 5 Aug. 2026].

Compartir e imprimir

Guardá la ficha, copiá su enlace permanente o imprimila como PDF.

Exportar referencia

Si usás un gestor bibliográfico, podés exportar el registro en los formatos más comunes.

Detalles del recurso

Información bibliográfica útil para confirmar que se trata del material correcto.

Título
Immune dysfunction in cirrhosis: distinct cytokines phenotypes according to cirrhosis severity
Autor / colaboradores
Dirchwolf, Melisa et al
Editorial
Elsevier
Año de publicación
2016
ISSN
1043-4666
ISSN
1043-4666
Idioma
Inglés

Materias

Explorá otros recursos relacionados a partir de estas materias.

Copiado